Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF)
International Journal of Rheumatic Diseases · 2026-11 · 29 (11)
DOI: 10.1111/1756-185x.70928 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 29.10.2026. Verfasst von Fatima Tahir und 6 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Department, Liverpool Hospital, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Gout, Medication Adherence, Gout Suppressants, Patient Care Team. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Royal Australasian College of Physicians (RACP) Research Establishment Fellowship, Sydney Partnership of Health, Education, Research and Enterprise (SPHERE), Implementation Science Platform Grant, Royal Australasian College of Physicians.
Abstract (Originalsprache)
Introduction
Adherence rates to urate lowering therapy in gout remain low. Successfully implemented in Switzerland, the Interprofessional Medication Adherence Program (IMAP) supports medication adherence through an ambulatory‐based model of care that includes pharmacists, motivational interviewing, and electronic adherence monitoring. We aimed to determine the facilitators and barriers to implementing IMAP for patients with gout in a hospital in Australia.
Methods
Multi‐stakeholder, semi‐structured interviews were analyzed using the Theoretical Domains Framework (TDF) for each stakeholder group and Implementation Mapping was used to identify target behaviors.
Results
A total of 51 interviews were conducted with patients ( n = 8), a general practitioner ( n = 1), pharmacists ( n = 8), rheumatologists ( n = 21), nurses ( n = 4), and decision/policy makers ( n = 9). Patients identified their health—reducing gout flares and improving function—as key facilitators, while barriers included environmental context and resources, such as time constraints. Pharmacists and nurses were motivated by professional role and identity, particularly the opportunity to extend their skillsets. However, pharmacists faced barriers related to environmental context and resources, including insufficient funding or managerial support. Nurses were keen to improve their knowledge and skills, such as training in motivational interviewing. Rheumatologists were driven by their goals of improving patient outcomes, but expressed concerns about ensuring governance over a pharmacist‐led program. For general practitioners, behaviors were facilitated by environmental context and resources, such as remuneration. Finally, decision/policy makers identified improving health system outcomes as key enablers, but emphasized the importance of program reach and cost‐effectiveness.
Conclusion
For successful implementation within our context, IMAP‐Gout needs to be adapted from a pharmacist‐led model to a nurse‐led model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Rheumatology Department, Liverpool Hospital, Sydney, New South Wales, Australia.
- School of Medicine, Western Sydney University, Sydney, New South Wales, Australia.
- South West Sydney Campuses, School of Clinical Medicine, UNSW Medicine & Health, Sydney, New South Wales, Australia.
- Transdisciplinary School, University of Technology, Sydney, New South Wales, Australia.
- Liverpool Physiotherapy Department, SWSLHD, Liverpool, New South Wales, Australia.
- School of Pharmacy, University of Sydney, Sydney, New South Wales, Australia.
ORCID-Profile: Fatima Tahir, Sacha Bossina, Fatima Rezae, David Martens
Förderung
- Royal Australasian College of Physicians (RACP) Research Establishment Fellowship
- Sydney Partnership of Health, Education, Research and Enterprise (SPHERE), Implementation Science Platform Grant
- Royal Australasian College of Physicians
Zitieren
APA
Tahir, F., Gul, H., Bossina, S., Rezae, F., Martens, D., Rickard, H., & Kelly, A. (2026). Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF). International Journal of Rheumatic Diseases, 29(11). https://doi.org/10.1111/1756-185x.70928
Vancouver
Tahir F, Gul H, Bossina S, Rezae F, Martens D, Rickard H, et al. Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF). International Journal of Rheumatic Diseases. 2026;29(11). doi:10.1111/1756-185x.70928
BibTeX
@article{Tahir2026,
author = {Tahir, Fatima and Gul, Hossai and Bossina, Sacha and Rezae, Fatima and Martens, David and Rickard, Helene and Kelly, Ayano},
title = {Adapting an Interprofessional Medication Adherence Program for Gout (IMAP‐Gout): A Theory‐Informed Pre‐Implementation Analysis Using the Theoretical Domains Framework (TDF)},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
volume = {29},
number = {11},
doi = {10.1111/1756-185x.70928}
}
EUVIMED